Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Revista Romana de Medicina de Laborator
Volume 21 (2013): Issue 3 (September 2013)
Open Access
The importance of the new prognostic scoring system for evaluating patients with lower-risk myelodysplastic syndrome at diagnosis
Aurelia Tatic
Aurelia Tatic
,
Cerasela Jardan
Cerasela Jardan
,
Otilia Georgescu
Otilia Georgescu
,
Oana Stanca
Oana Stanca
,
Madalina Vasilica
Madalina Vasilica
,
Sorina Badelita
Sorina Badelita
,
Ana Manuela Crisan
Ana Manuela Crisan
,
Adriana Colita
Adriana Colita
,
Dan Colita
Dan Colita
,
Genica Vulcan
Genica Vulcan
,
Anca Roxana Lupu
Anca Roxana Lupu
,
Ionel Iosif
Ionel Iosif
and
Daniel Coriu
Daniel Coriu
| Sep 19, 2013
Revista Romana de Medicina de Laborator
Volume 21 (2013): Issue 3 (September 2013)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Sep 19, 2013
Page range:
343 - 351
DOI:
https://doi.org/10.2478/rrlm-2013-0033
This content is open access.
Aurelia Tatic
Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania
Cerasela Jardan
Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania
Otilia Georgescu
Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
Oana Stanca
Hematology Department, Coltea Hospital, Bucharest, Romania
University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania
Madalina Vasilica
Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
Sorina Badelita
Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
Ana Manuela Crisan
Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania
Adriana Colita
Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
Dan Colita
Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
Genica Vulcan
Hiperdia, Brasov, Romania
Anca Roxana Lupu
Hematology Department, Coltea Hospital, Bucharest, Romania
University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania
Ionel Iosif
National Centre for Prevention and Diseases Control, Bucharest, Romania
Daniel Coriu
Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania